Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alirocumab in Japanese Patients with Hypercholesterolemia (ODYSSEY-NIPPON)
NCT02584504Phase 3Completed
- Sponsor
- Sanofi
- Start
- Nov 2015
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alirocumab in hypercholesterolemia, sponsored by Sanofi. Started Nov 2015; status: completed.
02
Drugs
alirocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02584504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584504.